US Stock MarketDetailed Quotes

OBIO Orchestra BioMed

Watchlist

5.660
-0.470-7.67%

Close Nov 12 16:00 ET

6.050
+0.390+6.89%

Post 16:36 ET

214.09MMarket Cap-3649P/E (TTM)

Orchestra BioMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

2.71%-10.21M

8.81%-13.11M

-57.49%-46.13M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-50.75%-29.29M

-8.74M

-7.26M

Net income from continuing operations

-32.66%-15.98M

-23.06%-13.46M

-46.16%-49.12M

-31.47%-12.82M

-29.51%-13.32M

-53.51%-12.05M

-90.96%-10.94M

-46.03%-33.61M

---9.75M

---10.28M

Operating gains losses

----

-28.89%1.45M

409.29%1.15M

--0

102.76%294K

390.70%2.03M

--226K

---36K

Depreciation and amortization

1.37%74K

4.23%74K

29.28%287K

2.86%72K

31.48%71K

46.00%73K

47.92%71K

22.65%222K

--70K

--54K

Other non cash items

82.12%-155K

39.42%-524K

-2,394.78%-3.08M

-15.53%-476K

-566.13%-867K

-601.16%-867K

-562.57%-865K

-38.25%134K

---412K

--186K

Change In working capital

401.80%3.07M

58.47%-1.83M

-633.26%-3.31M

-223.40%-116K

115.09%613K

208.32%612K

-1,566.42%-4.42M

-117.37%-451K

--94K

--285K

-Change in receivables

86.32%-13K

60.00%32K

-112.00%-3K

---13K

631.25%85K

-9,400.00%-95K

-52.38%20K

-46.81%25K

--0

---16K

-Change in inventory

-16.67%45K

-29.55%31K

162.98%131K

-114.81%-8K

120.81%41K

153.47%54K

22.22%44K

-20,900.00%-208K

--54K

---197K

-Change in prepaid assets

-85.40%113K

95.99%-60K

-77.90%-781K

-997.22%-323K

2,550.00%265K

238.96%774K

-2,179.17%-1.5M

-1,613.79%-439K

--36K

--10K

-Change in payables and accrued expense

378.31%3.73M

28.86%-1.28M

-95.67%145K

-53.40%493K

-58.82%668K

65.74%779K

-988.61%-1.8M

210.95%3.35M

--1.06M

--1.62M

-Change in other current liabilities

0.00%-172K

62.72%-63K

-117.24%-693K

-43.90%-177K

-18.24%-175K

-17.01%-172K

-270.71%-169K

---319K

---123K

---148K

-Change in other working capital

13.74%-628K

51.23%-497K

26.42%-2.11M

90.55%-88K

72.52%-271K

-217.90%-728K

-42.32%-1.02M

-298.47%-2.86M

---931K

---986K

Cash from discontinued investing activities

Operating cash flow

2.71%-10.21M

8.81%-13.11M

-57.49%-46.13M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-50.75%-29.29M

---8.74M

---7.26M

Investing cash flow

Cash flow from continuing investing activities

28.41%10.42M

113.46%5.86M

116.67%10.69M

152.31%33.15M

5,879.91%12.95M

1,812.66%8.12M

-92,514.89%-43.53M

-592.60%-64.12M

-63.38M

-224K

Net PPE purchase and sale

-296.30%-107K

77.14%-8K

86.80%-78K

105.56%3K

91.52%-19K

89.85%-27K

25.53%-35K

-115.69%-591K

---54K

---224K

Net investment purchase and sale

29.29%10.53M

113.49%5.87M

116.94%10.77M

152.35%33.15M

--12.97M

4,015.87%8.15M

---43.49M

-578.00%-63.53M

---63.32M

--0

Cash from discontinued investing activities

Investing cash flow

28.41%10.42M

113.46%5.86M

116.67%10.69M

152.31%33.15M

5,879.91%12.95M

1,812.66%8.12M

-92,514.89%-43.53M

-592.60%-64.12M

---63.38M

---224K

Financing cash flow

Cash flow from continuing financing activities

98.84%171K

-99.97%18K

-55.24%46.22M

-110.14%-10.7M

100.16%4K

-99.90%86K

129.45%56.82M

2,685.95%103.26M

-5.09M

-2.5M

Net issuance payments of debt

----

-405.26%-10.85M

---10.85M

----

188.85%3.55M

--0

Net common stock issuance

----

--0

----

--109.83M

--0

----

Proceeds from stock option exercised by employees

98.84%171K

63.64%18K

33.68%254K

1,630.00%153K

0.00%4K

-11.34%86K

-88.89%11K

2,614.29%190K

---10K

--4K

Net other financing activities

----

650.64%56.81M

--0

3,626.38%56.81M

---10.32M

---5.08M

---2.5M

Cash from discontinued financing activities

Financing cash flow

98.84%171K

-99.97%18K

-55.24%46.22M

-110.14%-10.7M

100.16%4K

-99.90%86K

129.45%56.82M

2,685.95%103.26M

---5.09M

---2.5M

Net cash flow

Beginning cash position

24.76%23.32M

54.46%30.56M

99.07%19.78M

-80.33%19.08M

-84.66%16.41M

-36.26%18.7M

99.07%19.78M

-51.15%9.94M

--97M

--106.97M

Current changes in cash

117.02%389K

-564.37%-7.24M

9.44%10.78M

114.87%11.48M

126.75%2.67M

-102.94%-2.29M

-105.62%-1.09M

194.63%9.85M

---77.21M

---9.98M

End cash Position

44.51%23.71M

24.76%23.32M

54.46%30.56M

-80.33%19.08M

-84.66%16.41M

-36.26%18.7M

99.07%19.78M

--19.78M

--97M

Free cash flow

1.94%-10.31M

8.98%-13.12M

-54.64%-46.21M

-24.70%-10.97M

-37.71%-10.3M

-27.77%-10.52M

-168.40%-14.42M

-51.65%-29.88M

---8.8M

---7.48M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	2.71%-10.21M	8.81%-13.11M	-57.49%-46.13M	-25.50%-10.97M	-41.70%-10.28M	-31.70%-10.49M	-170.12%-14.38M	-50.75%-29.29M	-8.74M	-7.26M
Net income from continuing operations	-32.66%-15.98M	-23.06%-13.46M	-46.16%-49.12M	-31.47%-12.82M	-29.51%-13.32M	-53.51%-12.05M	-90.96%-10.94M	-46.03%-33.61M	---9.75M	---10.28M
Operating gains losses	----	----	-28.89%1.45M	409.29%1.15M	--0	--0	102.76%294K	390.70%2.03M	--226K	---36K
Depreciation and amortization	1.37%74K	4.23%74K	29.28%287K	2.86%72K	31.48%71K	46.00%73K	47.92%71K	22.65%222K	--70K	--54K
Other non cash items	82.12%-155K	39.42%-524K	-2,394.78%-3.08M	-15.53%-476K	-566.13%-867K	-601.16%-867K	-562.57%-865K	-38.25%134K	---412K	--186K
Change In working capital	401.80%3.07M	58.47%-1.83M	-633.26%-3.31M	-223.40%-116K	115.09%613K	208.32%612K	-1,566.42%-4.42M	-117.37%-451K	--94K	--285K
-Change in receivables	86.32%-13K	60.00%32K	-112.00%-3K	---13K	631.25%85K	-9,400.00%-95K	-52.38%20K	-46.81%25K	--0	---16K
-Change in inventory	-16.67%45K	-29.55%31K	162.98%131K	-114.81%-8K	120.81%41K	153.47%54K	22.22%44K	-20,900.00%-208K	--54K	---197K
-Change in prepaid assets	-85.40%113K	95.99%-60K	-77.90%-781K	-997.22%-323K	2,550.00%265K	238.96%774K	-2,179.17%-1.5M	-1,613.79%-439K	--36K	--10K
-Change in payables and accrued expense	378.31%3.73M	28.86%-1.28M	-95.67%145K	-53.40%493K	-58.82%668K	65.74%779K	-988.61%-1.8M	210.95%3.35M	--1.06M	--1.62M
-Change in other current liabilities	0.00%-172K	62.72%-63K	-117.24%-693K	-43.90%-177K	-18.24%-175K	-17.01%-172K	-270.71%-169K	---319K	---123K	---148K
-Change in other working capital	13.74%-628K	51.23%-497K	26.42%-2.11M	90.55%-88K	72.52%-271K	-217.90%-728K	-42.32%-1.02M	-298.47%-2.86M	---931K	---986K
Cash from discontinued investing activities
Operating cash flow	2.71%-10.21M	8.81%-13.11M	-57.49%-46.13M	-25.50%-10.97M	-41.70%-10.28M	-31.70%-10.49M	-170.12%-14.38M	-50.75%-29.29M	---8.74M	---7.26M
Investing cash flow
Cash flow from continuing investing activities	28.41%10.42M	113.46%5.86M	116.67%10.69M	152.31%33.15M	5,879.91%12.95M	1,812.66%8.12M	-92,514.89%-43.53M	-592.60%-64.12M	-63.38M	-224K
Net PPE purchase and sale	-296.30%-107K	77.14%-8K	86.80%-78K	105.56%3K	91.52%-19K	89.85%-27K	25.53%-35K	-115.69%-591K	---54K	---224K
Net investment purchase and sale	29.29%10.53M	113.49%5.87M	116.94%10.77M	152.35%33.15M	--12.97M	4,015.87%8.15M	---43.49M	-578.00%-63.53M	---63.32M	--0
Cash from discontinued investing activities
Investing cash flow	28.41%10.42M	113.46%5.86M	116.67%10.69M	152.31%33.15M	5,879.91%12.95M	1,812.66%8.12M	-92,514.89%-43.53M	-592.60%-64.12M	---63.38M	---224K
Financing cash flow
Cash flow from continuing financing activities	98.84%171K	-99.97%18K	-55.24%46.22M	-110.14%-10.7M	100.16%4K	-99.90%86K	129.45%56.82M	2,685.95%103.26M	-5.09M	-2.5M
Net issuance payments of debt	----	----	-405.26%-10.85M	---10.85M	----	----	----	188.85%3.55M	--0	--0
Net common stock issuance	----	----	--0	--0	----	----	----	--109.83M	--0	----
Proceeds from stock option exercised by employees	98.84%171K	63.64%18K	33.68%254K	1,630.00%153K	0.00%4K	-11.34%86K	-88.89%11K	2,614.29%190K	---10K	--4K
Net other financing activities	----	----	650.64%56.81M	--0	--0	--0	3,626.38%56.81M	---10.32M	---5.08M	---2.5M
Cash from discontinued financing activities
Financing cash flow	98.84%171K	-99.97%18K	-55.24%46.22M	-110.14%-10.7M	100.16%4K	-99.90%86K	129.45%56.82M	2,685.95%103.26M	---5.09M	---2.5M
Net cash flow
Beginning cash position	24.76%23.32M	54.46%30.56M	99.07%19.78M	-80.33%19.08M	-84.66%16.41M	-36.26%18.7M	99.07%19.78M	-51.15%9.94M	--97M	--106.97M
Current changes in cash	117.02%389K	-564.37%-7.24M	9.44%10.78M	114.87%11.48M	126.75%2.67M	-102.94%-2.29M	-105.62%-1.09M	194.63%9.85M	---77.21M	---9.98M
End cash Position	44.51%23.71M	24.76%23.32M	54.46%30.56M	54.46%30.56M	-80.33%19.08M	-84.66%16.41M	-36.26%18.7M	99.07%19.78M	--19.78M	--97M
Free cash flow	1.94%-10.31M	8.98%-13.12M	-54.64%-46.21M	-24.70%-10.97M	-37.71%-10.3M	-27.77%-10.52M	-168.40%-14.42M	-51.65%-29.88M	---8.8M	---7.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data